Oh, D., Qin, S., Antonuzzo, L., Tougeron, D., Lee, C., Tan, B. R., Ikeda, M., Wang, J., Lin, H., Lee, Y. S., McCoon, P., Valle, J. W. (2025). Analysis of clinically actionable alterations in baseline tumor versus plasma samples in participants of the TOPAZ-1 study of durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.4_suppl.625